Rabeprazole and Acute pulmonary oedema - a phase IV clinical study of FDA data

Summary:

Acute pulmonary oedema is reported as a side effect among people who take Rabeprazole (rabeprazole sodium), especially for people who are female, 60+ old, also take Pradaxa, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Acute pulmonary oedema when taking Rabeprazole. It is created by eHealthMe based on reports of 31,196 people who have side effects when taking Rabeprazole from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Acute pulmonary oedema?

Acute pulmonary oedema (sudden deposit of fluid in the lung)) is found to be associated with 585 drugs and 900 conditions by eHealthMe. Check the latest studies of Acute pulmonary oedema.

On Jul, 10, 2026

31,196 people reported to have side effects when taking Rabeprazole.
Among them, 15 people (0.05%) have Acute pulmonary oedema.

Could Rabeprazole cause Acute pulmonary oedema?

Among these 15 people:

What is the gender of people who have Acute pulmonary oedema when taking Rabeprazole? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Acute pulmonary oedema when taking Rabeprazole? *

What are other drugs people take besides Rabeprazole? *

What are other side effects people have besides Acute pulmonary oedema? *

Nausea And Vomiting: 4 people, 26.67%
High Blood Pressure: 4 people, 26.67%
Pleural Effusion (water on the lungs): 4 people, 26.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 20.00%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 3 people, 20.00%
Lobar Pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung): 3 people, 20.00%
Streptococcal Sepsis (whole body inflammation by streptococcal): 3 people, 20.00%
Diarrhea: 3 people, 20.00%
Haemorrhage (bleeding): 2 people, 13.33%
Fluid Overload (too much fluid in the blood): 2 people, 13.33%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 33.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%
Indigestion: 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Asthma: 2 people, 13.33%
Bacterial Infection: 1 person, 6.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 6.67%
Gout (uric acid crystals building up in the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and have Acute pulmonary oedema?

- Check whether Acute pulmonary oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole:

Rabeprazole (31,689 reports)

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute pulmonary oedema:

Acute pulmonary oedema (585 drugs)

Browse all the conditions that are associated with Acute pulmonary oedema:

Acute pulmonary oedema (900 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole) and Rabeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.